Potential of Stem Cell-Based Therapy for Ischemic Stroke

Ischemic stroke is one of the major health problems worldwide. The only FDA approved anti-thrombotic drug for acute ischemic stroke is the tissue plasminogen activator. Several studies have been devoted to assessing the therapeutic potential of different types of stem cells such as neural stem cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Marei, Hany E., Hasan, A., Rizzi, R., Althani, A., Afifi, N., Cenciarelli, C., Caceci, Thomas, Shuaib, Ashfaq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808289/
https://www.ncbi.nlm.nih.gov/pubmed/29467713
http://dx.doi.org/10.3389/fneur.2018.00034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808289/
https://www.ncbi.nlm.nih.gov/pubmed/29467713
http://dx.doi.org/10.3389/fneur.2018.00034

Ejemplares similares